The board’s annual report for 2023 shows that its budget and staff are 56 per cent and 18 per cent, respectively, above their ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

Even well-known drugs can cause entirely unpredictable effects on metabolism, Swiss researchers have shown. Rapidly mapping ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Data4Cure today announced an ongoing multi-year partnership with Pfizer, aimed at leveraging advanced analytics and knowledge graph AI to drive innovation in Pfizer’s drug discovery and development ...

Genialis and Debiopharm expand collaboration to develop RNA-based predictive biomarkers for DDR therapies, advancing precision oncology.

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients ...